- Home
- BME vs KIO Comparison
BME vs KIO Comparison
Compare BME & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BME | KIO |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | 2400 |
| Industry | Trusts Except Educational Religious and Charitable | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.8M | 478.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BME | KIO |
|---|---|---|
| Price | $42.02 | $11.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.0K | ★ 136.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 6.26% | ★ 10.82% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $28.37 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.53 | $10.52 |
| 52 Week High | $43.20 | $13.59 |
Technical Indicators
Market Signals| Indicator | BME | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 55.82 |
| Support Level | $41.58 | $11.65 |
| Resistance Level | $42.35 | $11.75 |
| Average True Range (ATR) | 0.44 | 0.07 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 85.11 | 87.50 |
Price Performance
Historical ComparisonAbout BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. The Fund's main objective is to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in a portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.